| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Chief Financial Officer | Chief Financial Officer +1 more
3 companies
Robertson Michelle is an EVP, Chief Financial Officer at EDIT, with reported holdings spanning 3 companies. Recent filings cover 0 purchases and 13 sales. Those positions are worth an estimated $1.1M at current prices.
Our model assigns Robertson Michelle a strong insider score of 75/100, based on 11 past trades. Over a 12-month horizon, 72.7% of those trades were profitable, with an average 12-month return of +30.5%.
Robertson Michelle's largest disclosed position is in EDIT as EVP, Chief Financial Officer, worth about $1.1M. The recent filings there lean toward selling, a net 18,163 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | GERN Geron Corporation | EVP, Chief Financial Officer | Sale+OE | 9,855 | $1.94 | $19,118.70 | -35.8% | -37.1% | - | |
| May 11, 2023 | EDIT Editas Medicine, Inc. | EVP, Chief Financial Officer | Sell | 949 | $9.87 | $9,368.53 | -0.9% | -7.5% | -44.4% | |
| Mar 3, 2023 | EDIT Editas Medicine, Inc. | EVP, Chief Financial Officer | Sell | 184 | $8.89 | $1,635.76 | -0.2% | +6.6% | +17.5% | |
| Feb 13, 2023 | EDIT Editas Medicine, Inc. | EVP, Chief Financial Officer | Sell | 4,287 | $9.67 | $41,435.14 | -5.3% | +0.2% | -25.9% | |
| Jan 10, 2023 | EDIT Editas Medicine, Inc. | EVP, Chief Financial Officer | Sell | 1,752 | $8.16 | $14,296.50 | -2.1% | -20.0% | +14.1% | |
| Dec 5, 2022 | EDIT Editas Medicine, Inc. | EVP, Chief Financial Officer | Sell | 193 | $10.23 | $1,974.39 | -0.2% | -12.8% | +11.7% | |
| Sep 6, 2022 | EDIT Editas Medicine, Inc. | EVP, Chief Financial Officer | Sell | 192 | $15.01 | $2,881.92 | -0.2% | -31.3% | -36.2% | |
| Jun 3, 2022 | EDIT Editas Medicine, Inc. | EVP, Chief Financial Officer | Sell | 1,527 | $11.54 | $17,616.85 | -1.8% | +29.5% | -18.8% | |
| Mar 3, 2022 | EDIT Editas Medicine, Inc. | EVP, Chief Financial Officer | Sell | 767 | $17.33 | $13,290.35 | -0.9% | -34.5% | -46.5% | |
| Jan 11, 2022 | EDIT Editas Medicine, Inc. | Chief Financial Officer | Sell | 1,744 | $25.70 | $44,820.80 | -5.3% | -31.8% | -66.9% |